These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18695506)

  • 1. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.
    Ubhi K; Rockenstein E; Mante M; Patrick C; Adame A; Thukral M; Shults C; Masliah E
    Neuroreport; 2008 Aug; 19(13):1271-6. PubMed ID: 18695506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.
    Heras-Garvin A; Weckbecker D; Ryazanov S; Leonov A; Griesinger C; Giese A; Wenning GK; Stefanova N
    Mov Disord; 2019 Feb; 34(2):255-263. PubMed ID: 30452793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic approaches in multiple system atrophy.
    Palma JA; Kaufmann H
    Clin Auton Res; 2015 Feb; 25(1):37-45. PubMed ID: 24928797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation.
    Papay R; Zuscik MJ; Ross SA; Yun J; McCune DF; Gonzalez-Cabrera P; Gaivin R; Drazba J; Perez DM
    J Neurochem; 2002 Nov; 83(3):623-34. PubMed ID: 12390524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
    J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis.
    Fellner L; Buchinger E; Brueck D; Irschick R; Wenning GK; Stefanova N
    BMC Neurosci; 2018 May; 19(1):32. PubMed ID: 29783943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
    Nakayama K; Suzuki Y; Yazawa I
    Am J Pathol; 2009 Apr; 174(4):1471-80. PubMed ID: 19286568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
    Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
    Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy.
    Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH
    PLoS One; 2013; 8(1):e55243. PubMed ID: 23372841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
    Krejciova Z; Carlson GA; Giles K; Prusiner SB
    Acta Neuropathol Commun; 2019 May; 7(1):81. PubMed ID: 31109379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.
    Suzuki Y; Jin C; Iwase T; Yazawa I
    J Biol Chem; 2014 Aug; 289(35):24374-82. PubMed ID: 25028513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.